MYL

Mylan Inc. Press Releases

$57.51
*  
0.68
1.2%
Get MYL Alerts
*Delayed - data as of Dec. 19, 2014  -  Find a broker to begin trading MYL now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Mylan to Present at the J.P. Morgan 33rd Annual Healthcare Conference
12/17/2014 9:00:00 AM - PR Newswire
▲7.37 % Price Change since this news event. The Volume Ratio is 1.07.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Mylan Launches Generic Robaxin® Injection
12/11/2014 7:30:00 AM - PR Newswire
▲4.58 % Price Change since this news event. The Volume Ratio is 0.81.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Mylan Launches First Generic Version of Orapred ODT®
12/11/2014 7:00:00 AM - PR Newswire
▲4.58 % Price Change since this news event. The Volume Ratio is 0.81.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Mylan Launches One of First Available Generic Versions of Celebrex® Capsules
12/10/2014 7:30:00 AM - PR Newswire
▲1.66 % Price Change since this news event. The Volume Ratio is 1.28.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


World TeamTennis and Mylan Announce Title Sponsorship Extension Through 2017
12/8/2014 5:01:00 AM - PR Newswire
▼-1.51 % Price Change since this news event. The Volume Ratio is 1.49.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Mylan receives tentative FDA approval for paediatric formulations of abacavir/lamivudine through innovative collaboration with ViiV Healthcare and Clinton Health Access Initiative
12/4/2014 11:29:00 AM - PR Newswire


Mylan receives tentative FDA approval for pediatric formulations of abacavir/lamivudine through innovative collaboration with ViiV Healthcare and Clinton Health Access Initiative
12/4/2014 10:00:00 AM - PR Newswire
▼-1.76 % Price Change since this news event. The Volume Ratio is 0.71.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Mylan and Canadian AIDS Society Team up in Cross-Country Relay to Accelerate Canada's Fight Against HIV/AIDS
12/1/2014 9:00:00 PM - PR Newswire
▼-0.54 % Price Change since this news event. The Volume Ratio is 0.87.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Mylan Signs Agreement with Gilead to Enhance Access to Tenofovir Alafenamide (TAF)-based HIV Treatments in Developing Countries
12/1/2014 7:00:00 AM - PR Newswire
▼-1.88 % Price Change since this news event. The Volume Ratio is 1.03.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Mylan Confirms First-to-File Patent Challenge Relating to BREVIBLOC®
11/25/2014 7:30:00 AM - PR Newswire


Mylan Signs Strategic Alliance Agreement with Walt Disney Parks and Resorts to Enhance Access to EpiPen® (epinephrine) Auto-Injectors
11/7/2014 8:00:00 AM - PR Newswire
▲7.50 % Price Change since this news event. The Volume Ratio is 0.91.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Mylan Launches Generic Loestrin 24 Fe®
11/5/2014 7:30:00 AM - PR Newswire
▲7.00 % Price Change since this news event. The Volume Ratio is 0.64.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Mylan Third Quarter 2014 Adjusted Diluted EPS Increases 41% to $1.16
10/30/2014 4:05:00 PM - PR Newswire
▲5.78 % Price Change since this news event. The Volume Ratio is 3.27.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Mylan Launches Generic Viramune XR®
10/30/2014 12:48:00 PM - PR Newswire
▲11.43 % Price Change since this news event. The Volume Ratio is 1.56.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


EpiPen4Schools® Program Enhances Support of National Movement to Improve Anaphylaxis Preparedness and Access to Emergency Treatment in Schools
10/27/2014 8:01:00 AM - PR Newswire
▲12.92 % Price Change since this news event. The Volume Ratio is 0.57.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Mylan Launches Generic Combivir®
10/6/2014 7:30:00 AM - PR Newswire


Mylan Increases Third Quarter and Full Year 2014 Adjusted Diluted EPS Guidance Range
10/3/2014 7:00:00 AM - PR Newswire